The Kemaladewi Lab has moved from the UPMC Children's Hospital of Pittsburgh/University of Pittsburgh School of Medicine to the

U.S. Food and Drug Administration (FDA) Headquarters in Silver Spring, Maryland. 

 

We will continue researching disease pathophysiology and therapeutic interventions for pediatric rare diseases, while learning how to regulate them!

​

Please address any questions (or simply say Hi!) to Dr. Kemaladewi at dwi.kemaladewi@fda.hhs.gov